Last reviewed · How we verify

NCT03503838

A Pilot Study of Online Yoga for MPN Patients

Completed NA Last updated 25 February 2022
What this trial tests

NA trial testing Online Yoga in Quality of Life in 62 participants. Completed in 12 June 2017.

Timeline
23 September 2016
Primary endpoint
12 June 2017
12 June 2017

Quick facts

Lead sponsorArizona State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment62
Start date23 September 2016
Primary completion12 June 2017
Estimated completion12 June 2017

Drugs / interventions tested

Conditions studied

Sponsor

Arizona State University

Who can join

Eligibility, any sex, with Quality of Life or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Polycythemia vera (PV), essential thrombocytosis (ET), and myelofibrosis (MF) are chronic Philadelphia negative myeloproliferative neoplasms (MPNs) that are characterized by clonal proliferation of hematopoietic stem cells, intramedullary fibrosis, and splenomegaly. While disease manifestations may vary amongst the spectrum of MPNs, quality of life considerations including fatigue, concentration difficulties, pain, sleep disturbance, and depression are negatively affected in most MPN patients. Inflammation has been suggested to be involved in the development of disease-related symptoms. Specific pro-inflammatory cytokines (e.g., IL-1, IL-6, IL-8, and TNF-α) have been associated with particular patient-reported symptoms, including fatigue, abdominal complaints, microvascular symptoms, and constitutional symptoms. Pharmacologic therapy can positively impact MPN related symptoms, specifically with JAK inhibition, however, these treatments often come with negative side effects (e.g., anemia, thrombocytopenia). Much opportunity remains for improving MPN symptoms (i.e., fatigue, insomnia, loss of muscle mass, and debilitation) and quality of life. Yoga, a gentle form of meditative exercise, has been shown to improve symptom management and quality of life parameters in cancer patients and may be effective in improving MPN-related symptoms. Here we propose a study evaluating the efficacy of an online yoga intervention comparing a yoga group to a wait-list control group for improving symptom burden and quality of life in MPN patients. Secondarily, we plan to evaluate the feasibility of collecting potential biomarkers that are related to MPN disease-related activity, such as fatigue (i.e., cortisol and serum cytokines).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research.
    Huberty J, Eckert R, Dueck A, Kosiorek H, et al · · 2019 · cited 58× · PMID 31174535 · DOI 10.1186/s12906-019-2530-8

Verify or expand the search:

Other trials of Online Yoga

Trials testing the same drug.

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Other Arizona State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03503838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing